[1]
“Sglt-2 Inhibitors in Diabetic Type 2 Patients Nephroprotective Effects of (Empagliflozin)”, Gen. Rep., vol. 26, pp. 1–4, Nov. 2023, Accessed: Aug. 02, 2025. [Online]. Available: https://geniusrepo.net/index.php/1/article/view/277